Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile
Jay Karri, MD, MPH

@jaykarrimd

Interventional Pain and PM&R physician @UMMC.
Clinical interests: #MedEd, #Spine, #MSKUS.
Not medical advice. Views/opinions my own.

ID: 1148573684950609925

calendar_today09-07-2019 12:44:40

645 Tweet

1,1K Followers

1,1K Following

Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

It’s almost 2025—why can’t all medical journals adopt the same standards for formatting and citation styles? A unified approach would streamline research and spare authors endless formatting headaches.

James Noake (@drjn_sportsmed) 's Twitter Profile Photo

Another patient today with raging cervical radiculopathy - C5/6 confirmed on MRI Biceps weakness Symptoms approx 6 weeks, zero sleep 100% pain relief with oral steroid & NSAID protocol (no change in motor loss as yet) No rebound as yet after finishing meds 5 days ago I

Another patient today with raging cervical radiculopathy - C5/6 confirmed on MRI

Biceps weakness 

Symptoms approx 6 weeks, zero sleep 

100% pain relief with oral steroid & NSAID protocol (no change in motor loss as yet)

No rebound as yet after finishing meds 5 days ago

I
Bei Zhang, MD, MSc (@beizhangmd) 's Twitter Profile Photo

Excited to present with KO Jean Woo, MD !! The Implications of Mindsets and Biases in Behavioral Assessments for Disorders of Consciousness 0553 cdmcd.co/pMMm5P #ACRM2024

Excited to present with <a href="/ko400/">KO</a> <a href="/JeanWooMD/">Jean Woo, MD</a> !! 
The Implications of Mindsets and Biases in Behavioral Assessments for Disorders of Consciousness  0553 cdmcd.co/pMMm5P #ACRM2024
Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

Depth perception is key to safely perform interlaminar epidural injections! While AP views alone lack depth, I touch the inferior lamina, then switch to a CLO views to redirect my needle into the target interspace. This approach is efficient and gives me a secure bony backstop.

Depth perception is key to safely perform interlaminar epidural injections! 

While AP views alone lack depth, I touch the inferior lamina, then switch to a CLO views to redirect my needle into the target interspace. This approach is efficient and gives me a secure bony backstop.
Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

Do entry angles change safety profiles for interlaminar epidural entry? It comes down to the ratio of needle advancement:ventral progression! Perpendicular placement? 1 : 1 Shallow angles (45deg or less)? 1 : ~0.5 Millimeters matter, especially in the cervical spine!

Do entry angles change safety profiles for interlaminar epidural entry?

It comes down to the ratio of needle advancement:ventral progression!

Perpendicular placement? 1 : 1

Shallow angles (45deg or less)? 1 : ~0.5

Millimeters matter, especially in the cervical spine!
Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

Patient with 3 months of left-sided pain in L3 distribution but w/o motor/sensory deficits. MRI shows an L3/4 disc herniation...that is anterior, with no central canal, lateral recess, or foraminal compromise. I encounter this once a year. Thoughts and insights? James Noake

Patient with 3 months of left-sided pain in L3 distribution but w/o motor/sensory deficits. MRI shows an L3/4 disc herniation...that is anterior, with no central canal, lateral recess, or foraminal compromise. I encounter this once a year. Thoughts and insights?

<a href="/DrJN_SportsMed/">James Noake</a>
Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

⚠️Just learnt today: MRIs can be contraindicated after an iron infusion!⚠️ Some formulations contain ferromagnetic particles, which interfere with imaging and pose safety risks. Wait times vary based on the preparation, and can be as long as 3-6 months! bit.ly/4fOc29V

⚠️Just learnt today: MRIs can be contraindicated after an iron infusion!⚠️

Some formulations contain ferromagnetic particles, which interfere with imaging and pose safety risks.

Wait times vary based on the preparation, and can be as long as 3-6 months!

bit.ly/4fOc29V
Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

Fantastic work by Heather Jackson, PhD, APRN, FAANP and Katherine Cloud! The "Fundamentals of Excellent Pain Management Care" program was outstanding and drew a large, diverse, and engaged audience. ASRA Pain Medicine #ASRAFALL24

Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

Congenitally short pedicles can cause LSS with neurogenic claudication, and X-rays can be enough to raise suspicion. Studies suggest pedicle lengths ≤9.5 mm at L3, L4, L5 can align with LSS diagnosis. bit.ly/3B01iqg

Congenitally short pedicles can cause LSS with neurogenic claudication, and X-rays can be enough to raise suspicion. 

Studies suggest pedicle lengths ≤9.5 mm at L3, L4, L5 can align with LSS diagnosis. 

bit.ly/3B01iqg
Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

Join us for the next "Advanced Topics in Pain Medicine" lecture, where we discuss cervical TFESIs! This procedure is highly debated and rarely taught in fellowships. Whatever your stance, understanding the evidence is essential for informed practice. bit.ly/3CVUNFr

Join us for the next "Advanced Topics in Pain Medicine" lecture, where we discuss cervical TFESIs!

This procedure is highly debated and rarely taught in fellowships. Whatever your stance, understanding the evidence is essential for informed practice.

bit.ly/3CVUNFr
HemOnc Today (@hemonctoday) 's Twitter Profile Photo

Healio spoke with Ryan D'Souza, MD of Mayo Clinic about study data showing that more than 40% of patients with cancer treated with chemotherapy develop persistent peripheral nerve pain. #CIPN #Chemotherapy bit.ly/41Ab6C2

Jay Karri, MD, MPH (@jaykarrimd) 's Twitter Profile Photo

🚨Time to rethink the SCS trial-to-implant ratio?🚨 With recent implant rates >80%, are trial-to-implant ratios are still meaningful? Or is it time to update utilization metrics to include explant and per-capita ratios? Eellan Sivanesan, MD, FASA Ryan D'Souza, MD bit.ly/3QSdihN

BMJMedicine (@bmjmedicine) 's Twitter Profile Photo

In this editorial Jay Karri, MD, MPH and colleagues discuss Suzetrigine, a novel non-opioid analgesic targeting Nav1.8, that has recently gained FDA approval for moderate-to-severe acute pain. Read the full article here: bit.ly/44bIb8K Ryan D'Souza, MD

BMJMedicine (@bmjmedicine) 's Twitter Profile Photo

Suzetrigine, a novel non-opioid analgesic, has recently gained FDA approval for moderate-to-severe acute pain. While offering hope amid the opioid crisis, its ambiguous clinical benefits and trial limitations raise scrutiny. Jay Karri, MD, MPH Ryan D'Souza, MD bit.ly/44bIb8K